Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets Medical Dialogues Bureau10 April 2020 1:00 PM ISTHyderabad: Aurobindo Pharma Limited has announced that the Company has received the final approval from the US Food & Drug Administration (USFDA)...
Aurobindo Pharma faces CA Suit in US for concealing facts Medical Dialogues Bureau9 April 2020 1:36 PM ISTHyderabad: A class-action suit has been filed against some drug manufacturers, including Aurobindo Pharma and Emcure Pharmaceuticals, in a USA court...
Aurobindo, Sandoz call off 900 million US dollar deal Medical Dialogues Bureau2 April 2020 3:27 PM ISTNew Delhi: Aurobindo Pharma on Thursday said the USD 900 million deal to acquire Sandoz Inc''s US-based generic oral solids and dermatology...
NPPA directs 3 pharma cos to maintain stock of atleast 2.2 crore tablets of FDC Lopinavir and Ritoavir Medical Dialogues Bureau29 March 2020 1:19 PM ISTNew Delhi: The National Pharmaceuticals Pricing Authority (NPPA), Department of Pharmaceuticals directed 3 major manufacturers of the HIV Combo...
Eugia Pharma gets USFDA nod for generic drug: Aurobindo Pharma MD bureau1 Feb 2020 10:15 AM ISTNew Delhi: Aurobindo Pharma on Friday said its joint venture firm Eugia Pharma Specialities has received approval from the US health regulator to...
USFDA cautions Aurobindo Pharma's oral solids formulation facility of regulatory action MD bureau31 Jan 2020 1:29 PM ISTNEW DELHI: Drug firm Aurobindo Pharma on Thursday reported that the US health regulator has cautioned that its oral solids formulation manufacturing...
Aurobindo Pharma gets official action indicated classification from USFDA for its plant Meghna A Singhania30 Jan 2020 4:14 PM ISTNew Delhi: Aurobindo Pharma has announced that the US Food and Drug Administration (FDA) classified the inspection of the company's oral solids...
Aurobindo Pharma targets to achieve zero debt in three years sans Novartis deal Medical Dialogues Bureau26 Nov 2019 9:30 AM ISTIn September 2018, the USD three billion drug-maker, Aurobindo Pharma said its US subsidiary entered into an agreement to acquire commercial...
Aurobindo Pharma gets 14 USFDA observations for Pashamylaram facility Farhat Nasim15 Nov 2019 12:13 PM ISTThe US Food and Drug Administration (USFDA) inspected company's Unit IV, a general injectable formulation manufacturing facility situated at...
Aurobindo Pharma Q2 net profit up by 5 pc to Rs 640 crore Medical Dialogues Bureau14 Nov 2019 9:30 AM ISTManaging director of Aurobindo Pharma N Govindarajan said We had another quarter of healthy performance where we continued to grow in the US and...
Aurobindo Pharma USA recalls heartburn drug Ranitidine over cancer causing impurities Medical Dialogues Bureau10 Nov 2019 9:45 AM ISTAurobindo Pharma is second city-based drug company that has initiated the voluntary recall after the FDA announced an investigation into the reported...
Aurobindo Pharma Unit-7 documents inaccurate, misleading: USFDA Medical Dialogues Bureau11 Oct 2019 10:00 AM IST"The responsibilities and procedures applicable to the quality control unit are not fully followed. Several lists of documents requested were either...
